Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02382848 · ClinicalTrials.gov registry record · NA

Effectiveness of Prazosin in Bulimic Patients Experiencing Nightmares Due to PTSD

A NA study of Stress Disorders, Post-Traumatic and Bulimia Nervosa, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT02382848 is a NA study of Stress Disorders, Post-Traumatic and Bulimia Nervosa that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 9 participants, below the 156-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02382848, a NA study of Stress Disorders, Post-Traumatic and Bulimia Nervosa, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

This research is being done to find out how effective Prazosin is in the treatment of bulimic patients experiencing distressing nightmares using subjective and objective measures.

Interventions

  • DRUG Placebo
  • DRUG Prazosin

Study Locations (1)

Pennsylvania

  • Penn State College of Medicine, Milton S. Hershey Medical Center - Hershey

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2015-07
Est. Completion 2018-03-09
Phase NA

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT02382848

The ClinicalTrials.gov registry entry for NCT02382848 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 156-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (94% lower). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02382848 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02382848 about?

NCT02382848 is a clinical study titled "Effectiveness of Prazosin in Bulimic Patients Experiencing Nightmares Due to PTSD". This research is being done to find out how effective Prazosin is in the treatment of bulimic patients experiencing distressing nightmares using subjective and objective measures.

What is the current status of trial NCT02382848?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2015-07. Estimated completion is 2018-03-09.

What conditions does trial NCT02382848 study?

This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic, Bulimia Nervosa.

What interventions are being tested in trial NCT02382848?

The interventions under investigation include: Placebo (DRUG), Prazosin (DRUG).

Who is sponsoring clinical trial NCT02382848?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02382848 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress Disorders, Post-Traumatic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.